Ironwood Pharma Inc Class A (IRWD)
EBITDA Growth
74.49%
Quarterly · Period ending:
IRWD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported74.49%period ending
Latest reported74.49%period ending
IRWD Quarterly EBITDA YoY % (-51.14% → 74.49%)
Year-over-year change
High-resolution chart · PNG
IRWD ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 74.4903% | |
| 842.3635% | |
| -73.645% | |
| 181.8428% | |
| 73.7115% | |
| -184.127% | |
| -17.6108% | |
| -35.4392% | |
| -52.2979% | |
| -82.3123% | |
| -45.3238% | |
| -41.1121% | |
| -0.1082% | |
| 14.3895% | |
| 35.8606% | |
| 9.6828% | |
| -13.5865% | |
| 28.279% | |
| 1.9526% | |
| 34.4922% | |
| 96.6468% | |
| 323.0713% | |
| -4.1702% | |
| 43.2368% | |
| 46.9686% | |
| 194.2504% | |
| 1,303.1021% | |
| 120.9322% | |
| 307.4088% | |
| 59.5665% | |
| -117.4721% | |
| -732.3881% | |
| 66.8616% | |
| 28.822% | |
| 705.6075% | |
| -8.1706% | |
| -294.4371% | |
| -7,115.0808% | |
| -44.8811% | |
| 47.8673% | |
| 78.6557% | |
| 97.7818% | |
| 89.9977% | |
| -3.2269% | |
| 25.0433% | |
| 38.9977% | |
| 30.6556% | |
| 37.3129% | |
| 8.8005% | |
| 52.131% | |
| -6.2267% | |
| -205.4439% | |
| -50.1896% | |
| -161.3213% | |
| -859.3137% | |
| 363.6203% | |
| -136.665% | |
| -100.5424% | |
| 60% | |
| -32.2487% | |
| -1.1089% | |
| -24.1601% | |
| 53.9176% | |
| -99.9312% | |
| 7.9244% | |
| 23.7612% | |
| -51.1413% |